AMA to Medical Schools: Bolster Training on Health Economics
The American Medical Association (AMA) as part of a new policy is urging medical schools to bolster health economics… Read more
HEOR Feature
Featured
ISPOR Seeks Input From Members on Responses to Calls for Comments
The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is calling on its members to submit their feedback on recent calls for… Read more
Doctors Slam Price of Heart Drug They Helped Develop
Bloomberg recently spoke with several doctors involved in the development of Pfizer's new heart drug, tafamidis, who voiced their opposition to the… Read more
Analysis: Pelosi Plan Could Result in Fewer Drugs
House Speaker Nancy Pelosi's drug pricing plan, H.R.3, could result in 56 fewer drugs over 10 years, a new analysis by economic consulting firm Vital… Read more
